140 related articles for article (PubMed ID: 24528514)
1. Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity.
Fernández-Marcelo T; Frías C; Pascua I; de Juan C; Head J; Gómez A; Hernando F; Jarabo JR; Díaz-Rubio E; Torres AJ; Rouleau M; Benito M; Iniesta P
J Exp Clin Cancer Res; 2014 Feb; 33(1):19. PubMed ID: 24528514
[TBL] [Abstract][Full Text] [Related]
2. PARP3 interacts with FoxM1 to confer glioblastoma cell radioresistance.
Quan JJ; Song JN; Qu JQ
Tumour Biol; 2015 Nov; 36(11):8617-24. PubMed ID: 26040766
[TBL] [Abstract][Full Text] [Related]
3. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
4. Analysis of poly(ADP-Ribose) polymerases in Arabidopsis telomere biology.
Boltz KA; Jasti M; Townley JM; Shippen DE
PLoS One; 2014; 9(2):e88872. PubMed ID: 24551184
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression.
Boehler C; Gauthier LR; Mortusewicz O; Biard DS; Saliou JM; Bresson A; Sanglier-Cianferani S; Smith S; Schreiber V; Boussin F; Dantzer F
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2783-8. PubMed ID: 21270334
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene.
Ghosh U; Das N; Bhattacharyya NP
Mutat Res; 2007 Feb; 615(1-2):66-74. PubMed ID: 17141279
[TBL] [Abstract][Full Text] [Related]
7. The Development of a Biotinylated NAD
Ji M; Wang L; Xue N; Lai F; Zhang S; Jin J; Chen X
SLAS Discov; 2018 Jul; 23(6):545-553. PubMed ID: 29676938
[TBL] [Abstract][Full Text] [Related]
8. A key role for poly(ADP-ribose) polymerase 3 in ectodermal specification and neural crest development.
Rouleau M; Saxena V; Rodrigue A; Paquet ER; Gagnon A; Hendzel MJ; Masson JY; Ekker M; Poirier GG
PLoS One; 2011 Jan; 6(1):e15834. PubMed ID: 21264220
[TBL] [Abstract][Full Text] [Related]
9. Identification and Functional Characterizations of N-Terminal α-N-Methylation and Phosphorylation of Serine 461 in Human Poly(ADP-ribose) Polymerase 3.
Dai X; Rulten SL; You C; Caldecott KW; Wang Y
J Proteome Res; 2015 Jun; 14(6):2575-82. PubMed ID: 25886813
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells.
Ge L; Deng Z; Zhang Y; Shao W; Qiu Y; Cui D; Huang D
Oncol Rep; 2011 Dec; 26(6):1487-95. PubMed ID: 21922145
[TBL] [Abstract][Full Text] [Related]
11. PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.
Sharif-Askari B; Amrein L; Aloyz R; Panasci L
Breast Cancer Res Treat; 2018 Nov; 172(1):23-32. PubMed ID: 30039287
[TBL] [Abstract][Full Text] [Related]
12. PARP3 supervises G9a-mediated repression of adhesion and hypoxia-responsive genes in glioblastoma cells.
Nguekeu-Zebaze L; Hanini N; Noll A; Wadier N; Amé JC; Roegel L; Dantzer F
Sci Rep; 2022 Sep; 12(1):15534. PubMed ID: 36109561
[TBL] [Abstract][Full Text] [Related]
13. PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.
Beck C; Rodriguez-Vargas JM; Boehler C; Robert I; Heyer V; Hanini N; Gauthier LR; Tissier A; Schreiber V; Elofsson M; Reina San Martin B; Dantzer F
Cell Death Differ; 2019 Sep; 26(9):1615-1630. PubMed ID: 30442946
[TBL] [Abstract][Full Text] [Related]
14. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
[TBL] [Abstract][Full Text] [Related]
15. Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome.
Bieche I; Pennaneach V; Driouch K; Vacher S; Zaremba T; Susini A; Lidereau R; Hall J
Int J Cancer; 2013 Dec; 133(12):2791-800. PubMed ID: 23736962
[TBL] [Abstract][Full Text] [Related]
16. [Effect of tankyrase antisense oligonucleotide combined human telomerase reverse transcriptase antisense oligonucleotide on telomere dynamics in human lung adenocarcinoma A549 cells].
Lu HD; Huang T; Shen WZ; Zhen Y; Kong QZ
Ai Zheng; 2007 Nov; 26(11):1164-9. PubMed ID: 17991312
[TBL] [Abstract][Full Text] [Related]
17. Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells.
Ogretmen B; Schady D; Usta J; Wood R; Kraveka JM; Luberto C; Birbes H; Hannun YA; Obeid LM
J Biol Chem; 2001 Jul; 276(27):24901-10. PubMed ID: 11335714
[TBL] [Abstract][Full Text] [Related]
18. PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA.
Day TA; Layer JV; Cleary JP; Guha S; Stevenson KE; Tivey T; Kim S; Schinzel AC; Izzo F; Doench J; Root DE; Hahn WC; Price BD; Weinstock DM
Nat Commun; 2017 Apr; 8():15110. PubMed ID: 28447610
[TBL] [Abstract][Full Text] [Related]
19. Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation.
Zarkovic G; Belousova EA; Talhaoui I; Saint-Pierre C; Kutuzov MM; Matkarimov BT; Biard D; Gasparutto D; Lavrik OI; Ishchenko AA
Nucleic Acids Res; 2018 Mar; 46(5):2417-2431. PubMed ID: 29361132
[TBL] [Abstract][Full Text] [Related]
20. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].
Huang M; Wang Q; Zhang W; Li DR; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
